Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Neurochemistry|July 7, 2016
Molecular changes in the postmortem parkinsonian brainDamien Toulorge, Anthony H V Schapira, Rodolphe HajjCells|February 23, 2020
CD38 in Neurodegeneration and NeuroinflammationSerge Guerreiro, Anne-Laure Privat, Laurence Bressac, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson diseasePatrick P Michel, Damien Toulorge, Serge Guerreiro, et al.Journal of Neurochemistry|May 12, 2010
KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasisDamien Toulorge, Serge Guerreiro, Etienne C Hirsch, et al.Molecular Pharmacology|July 16, 2008
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channelsSerge Guerreiro, Damien Toulorge, Etienne Hirsch, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2011
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+Damien Toulorge, Serge Guerreiro, Audrey Hild, et al.Journal of Neurochemistry|March 24, 2009
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarizationSerge Guerreiro, Aurélie Ponceau, Damien Toulorge, et al.Scientific Reports|November 7, 2015
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's diseaseRodolphe Hajj, Aude Milet, Damien Toulorge, et al.Scientific Reports|January 9, 2015
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapyIlya Chumakov, Serguei Nabirotchkin, Nathalie Cholet, et al.Pageof 1